HEYL and susceptibility to pneumonia measurement: The association between the high frequency of partial-methylated HeyL promoter on the clinical-pathological findings in COVID-19 patients was clearly observed as the worst clinical outcomes including severe pneumonia, fever, dry cough, and ageusia and anosmia.